EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparison of 166Holmium and 90Yttrium TARE in Hepatocellular Carcinoma Treatment

Emirhan Harbi, Hamza Ugur Bozbey, Utku Mahir Yildirim, Oral Oncul, Didem Tastekin

Clinical Nuclear Medicine Open · 2026-06 · 3 (2)

DOI: 10.1097/nm9.0000000000000071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2026-06. Verfasst von Emirhan Harbi und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transarterial radioembolization (TARE) is widely used as an effective and safe local treatment option, especially in patients with intermediate and advanced hepatocellular carcinoma. Yttrium-90 ( 90 Y) microspheres, which have been used as the standard radioisotope for many years, enable the delivery of high doses of radiation to tumor tissue due to their pure β-emission properties. Holmium-166 ( 166 Ho) microspheres, on the other hand, offer the advantage of direct visualization via SPECT and magnetic resonance imaging (MRI), in addition to β-radiation, due to their γ-photon emission and paramagnetic properties. These features enable personalized dosimetry before and after treatment and provide more accurate predictions in treatment planning.

Zitieren

APA

Harbi, E., Bozbey, H. U., Yildirim, U. M., Oncul, O., & Tastekin, D. (2026). Comparison of 166Holmium and 90Yttrium TARE in Hepatocellular Carcinoma Treatment. Clinical Nuclear Medicine Open, 3(2). https://doi.org/10.1097/nm9.0000000000000071

Vancouver

Harbi E, Bozbey HU, Yildirim UM, Oncul O, Tastekin D. Comparison of 166Holmium and 90Yttrium TARE in Hepatocellular Carcinoma Treatment. Clinical Nuclear Medicine Open. 2026;3(2). doi:10.1097/nm9.0000000000000071

BibTeX
@article{Harbi2026,
  author = {Harbi, Emirhan and Bozbey, Hamza Ugur and Yildirim, Utku Mahir and Oncul, Oral and Tastekin, Didem},
  title = {Comparison of 166Holmium and 90Yttrium TARE in Hepatocellular Carcinoma Treatment},
  journal = {Clinical Nuclear Medicine Open},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.1097/nm9.0000000000000071}
}
Kostenlos starten →